SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded by Keyvan Mohajer, Majid Seyed Emami and James M. Hom on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing a surge in trading activity and investor sentiment following a significant quarterly revenue beat and raised full-year guidance that has triggered intense interest in a potential short squeeze. The community is heavily focused on the stock's high short interest and institutional accumulation, debating whether the move will result in a sustained breakout or a temporary squeeze as they analyze the impact of recent enterprise contract wins and upcoming acquisition synergies.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is experiencing intense volatility and downward pressure as shareholders react to a disappointing earnings report marked by a revenue miss and concerns over core brand volume. Investors are currently split between those who view the sell-off as an irrational overreaction to a long-term growth story and those who fear the brand is losing its competitive edge to rivals.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk Inc. is seeing intense community debate and high volatility as investors balance a strong balance sheet against growth concerns ahead of earnings. While some shareholders express frustration with management and recent stock performance, others are closely tracking institutional accumulation and technical setups, viewing the current price as a potential contrarian value opportunity.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is experiencing extreme volatility and high volume as the first post-IPO lockup expiration triggers a intense standoff between bears anticipating a sell-off and bulls betting that long-term investors will hold. Community members are actively debating whether the price resilience signifies institutional accumulation or a sophisticated trap for retail traders following the massive increase in available float.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is driving significant market attention as investors closely monitor potential entry points and momentum shifts within the software sector. The community is actively debating the stock's consolidation patterns and the strength of its recent growth trajectory.

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance is experiencing significant investor attention following record-breaking Q2 financial results, highlighted by strong revenue growth and improving gross margins that signal a successful commercial scale-up. The community is actively discussing the company's expanding treatment center network, the potential for upward guidance revisions, and the upcoming data readouts for its lung cancer pipeline as core drivers for future valuation.

Redwire Corp. engages in the development and provision of space and defense technologies and mission-critical solutions for government, commercial, and civil customers. Its offerings include spacecraft platforms, space infrastructure, avionics, sensors and payloads, power generation systems, radio frequency systems, microgravity research and manufacturing technologies, autonomous systems, optical sensors, and digital engineering solutions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwire is gaining significant momentum as investors digest a major $981 million Space Force contract award, fueling active discussions about the company's expanding role in defense and space infrastructure. Community members are closely monitoring the upcoming earnings release and recent institutional accumulation, with many debating the stock's potential for a short squeeze amidst high short interest and broader sector recovery.

Western Digital Corp. engages in the development, manufacture, marketing, and sale of data storage devices and solutions. The company was founded by Alvin B. Phillips in 1970 and is headquartered in San Jose, CA.

Western Digital Corp.

Western Digital is trending as investors debate the impact of slowing memory shipments and margin outlooks following an earnings beat, with the community split between viewing the sharp price decline as a buying opportunity based on strong long-term AI storage demand and fearing a cooling industry cycle. While some analysts maintain optimistic price targets, sentiment remains volatile as traders watch for technical support levels and gauge institutional reactions to these mixed fundamentals.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk Corp is trending as investors react to stellar earnings and revenue growth, with the community actively debating whether the significant pullback serves as a strategic buying opportunity or a signal of a cooling memory cycle. Discussion is heavily focused on the company's strong guidance, the upcoming Investor Day, and the potential impact of a massive share buyback program amid broader sector volatility.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is seeing significant social media activity as traders speculate on potential commercial validation following recent high-profile hiring and partnerships, while many discuss the impact of potential US restrictions on Chinese optical components. Community sentiment remains polarized, with bulls highlighting the stock's discounted valuation and long-term AI infrastructure potential, while others express frustration over the lack of revenue updates and current price volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Medical Stocks To Research - January 9th

Eli Lilly and Company, Novo Nordisk A/S, Revolution Medicines, Thermo Fisher Scientific, UnitedHealth Group, Cidara Therapeutics, and Merck & Co., Inc. are the seven Medical stocks to watch today...

Biotech Stocks Worth Watching - January 8th

Cidara Therapeutics, Abivax, and Vertex Pharmaceuticals are the three Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of publicly traded...

Merck to Complete Acquisition of Cidara Therapeutics

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the successful completion of the cash tender offer, through a subsidiary, for all the outstanding shares of...

Cidara Therapeutics, Inc. (NASDAQ:CDTX) Receives Consensus Recommendation of "Hold" from Analysts

Cidara Therapeutics, Inc. (NASDAQ:CDTX - Get Free Report) has been assigned a consensus recommendation of "Hold" from the twelve brokerages that are presently covering the company, MarketBeat.com...

Biotech Stocks To Follow Now - January 5th

Amicus Therapeutics, Danaher, argenex, Cidara Therapeutics, United Therapeutics, Vertex Pharmaceuticals, and Moderna are the seven Biotech stocks to watch today, according to MarketBeat's stock...

Cidara Therapeutics (NASDAQ:CDTX) Hits New 12-Month High - Here's Why

Cidara Therapeutics (NASDAQ:CDTX) Sets New 1-Year High - Here's Why...

Promising Biotech Stocks To Consider - January 4th

Danaher, Vertex Pharmaceuticals, Cidara Therapeutics, Moderna, and United Therapeutics are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are...

Biotech Stocks To Watch Today - January 3rd

Danaher, Vertex Pharmaceuticals, Cidara Therapeutics, Moderna, United Therapeutics, argenex, and Abivax are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool...

Top Biotech Stocks To Watch Now - January 2nd

Danaher, Moderna, and Cidara Therapeutics are the three Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are publicly traded shares of companies that use...

Is Cidara Therapeutics a Buy After HighVista Strategies Initiated a Position in the Stock?

Key PointsHighVista Strategies initiated a position in Cidara Therapeutics, buying 70,904 shares valued at $6.79 million...

Cidara Therapeutics, Inc. engages in developing targeted immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases. Its platform, Cloudbreak, enables development of novel drug-Fc conjugates (DFCs) that inhibit specific disease targets while simultaneously engaging the immune system. The company was founded by Kevin M. Forrest, Kevin J. Judice, and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA.

Cidara Therapeutics Inc

Cidara Therapeutics Stock Rockets Over 700% This Year — Then Wall Street Turns Neutral On Merck Takeover 

Equity

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

CDTXCidara Therapeutics Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest CDTX News